ACTH receptor antagonists (Ipsen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameACTH receptor antagonists (Ipsen)
Drug Alias NameACTH Receptor Inhibitors (Ipsen)MC2 receptor antagonists (Ipsen)melanocortin 2 receptor antagonists (Ipsen)ACTH(1-39)IRC-274 +[6
ClassificationSmall molecules
Mechanisms of ActionMelanocortin receptor 2 antagonists
TargetsMelanocortin receptor 2
Therapy Area/IndicationsPituitary ACTH Hypersecretion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen SA
Active IndicationsN/A
Inactive IndicationsPituitary ACTH Hypersecretion

Other Information

ATC CodeN/A
Related LinksN/A